Literature DB >> 20100859

Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control.

Jessica G Cole1, Nanette B Fulcher, Ann E Jerse.   

Abstract

The neisserial opacity (Opa) proteins are a family of antigenically distinct outer membrane proteins that undergo phase-variable expression. Opa(+) variants of Neisseria gonorrhoeae strain FA1090 are selected in a cyclical pattern from the lower genital tract of estradiol-treated mice. Here we show that cyclical recovery of Opa(+) gonococci does not occur in ovariectomized mice; therefore, the reproductive cycle plays a role in the selection kinetics in vivo. As predicted by the selection pattern shown by wild-type gonococci, we demonstrated that a constitutive Opa-expressing strain was more fit than an Opa-deficient mutant in the early and late phases of infection. We found no evidence that Opa-mediated colonization selects for Opa(+) variants during murine infection based on adherence assays with cultured murine epithelial cells. We also tested the hypothesis that complement selects for Opa protein expression during infection. Although some Opa(+) variants of a serum-sensitive derivative of strain FA1090 were more resistant to the bactericidal activity of normal human serum, selection for Opa expression was not abrogated in C3-depleted mice. Finally, as previously reported, Opa(+) gonococci were more sensitive to serine proteases. Thus, proteases or protease inhibitors may contribute to the observed in vivo selection pattern. We concluded that Opa proteins promote persistence of N. gonorrhoeae in the female genital tract and that opa gene phase variation allows gonococci to evade or capitalize upon unidentified host factors of the mammalian reproductive cycle. This work revealed an intimate interaction between pathogen and host and provides evidence that hormonally related factors shape bacterial adaptation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100859      PMCID: PMC2849431          DOI: 10.1128/IAI.00996-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle.

Authors:  Tetsuya Hirata; Yutaka Osuga; Kahori Hamasaki; Yasushi Hirota; Emi Nose; Chieko Morimoto; Miyuki Harada; Yuri Takemura; Kaori Koga; Osamu Yoshino; Toshiki Tajima; Akiko Hasegawa; Tetsu Yano; Yuji Taketani
Journal:  J Reprod Immunol       Date:  2007-02-12       Impact factor: 4.054

2.  Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.

Authors:  Hong Wu; Ann E Jerse
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells.

Authors:  Hortense Slevogt; Solveig Zabel; Bastian Opitz; Andreas Hocke; Julia Eitel; Philippe D N'guessan; Lothar Lucka; Kristian Riesbeck; Wolfgang Zimmermann; Janine Zweigner; Bettina Temmesfeld-Wollbrueck; Norbert Suttorp; Bernhard B Singer
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

4.  Standardization of the Whitten Effect to induce susceptibility to Neisseria gonorrhoeae in female mice.

Authors:  S J Dalal; J S Estep; I E Valentin-Bon; A E Jerse
Journal:  Contemp Top Lab Anim Sci       Date:  2001-03

5.  Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

Authors:  Jutamas Ngampasutadol; Sanjay Ram; Anna M Blom; Hanna Jarva; Ann E Jerse; Egil Lien; Jon Goguen; Sunita Gulati; Peter A Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

6.  An evaluation of gonorrhea case findings in the chronically infected female.

Authors:  D W Johnson; K K Holmes; P A Kvale; C W Halverson; W P Hirsch
Journal:  Am J Epidemiol       Date:  1969-11       Impact factor: 4.897

7.  Resistance of mice to genital infection with Neisseria gonorrhoeae.

Authors:  A P Johnson; M Tuffrey; D Taylor-Robinson
Journal:  J Med Microbiol       Date:  1989-09       Impact factor: 2.472

8.  Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness.

Authors:  Douglas M Warner; William M Shafer; Ann E Jerse
Journal:  Mol Microbiol       Date:  2008-08-27       Impact factor: 3.501

9.  A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes.

Authors:  Hong Wu; Angel A Soler-García; Ann E Jerse
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

10.  Mutational analysis of human CEACAM1: the potential of receptor polymorphism in increasing host susceptibility to bacterial infection.

Authors:  Silvia Villullas; Darryl J Hill; Richard B Sessions; Jon Rea; Mumtaz Virji
Journal:  Cell Microbiol       Date:  2006-08-31       Impact factor: 3.715

View more
  30 in total

1.  Deciphering the Function of New Gonococcal Vaccine Antigens Using Phenotypic Microarrays.

Authors:  Benjamin I Baarda; Sarah Emerson; Philip J Proteau; Aleksandra E Sikora
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

2.  Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Authors:  Morris D Cooper; Melissa H Roberts; Ona L Barauskas; Gary A Jarvis
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

Review 3.  Fur-mediated global regulatory circuits in pathogenic Neisseria species.

Authors:  Chunxiao Yu; Caroline Attardo Genco
Journal:  J Bacteriol       Date:  2012-08-10       Impact factor: 3.490

4.  Constitutively Opa-expressing and Opa-deficient neisseria gonorrhoeae strains differentially stimulate and survive exposure to human neutrophils.

Authors:  Louise M Ball; Alison K Criss
Journal:  J Bacteriol       Date:  2013-04-26       Impact factor: 3.490

5.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

6.  Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Bo Zheng; Caleb Carr; Isaac Bass; Sunita Gulati; Rosane B DeOliveira; Severin Gose; George W Reed; Marina Botto; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2018-09-28       Impact factor: 5.422

7.  Opa+ Neisseria gonorrhoeae exhibits reduced survival in human neutrophils via Src family kinase-mediated bacterial trafficking into mature phagolysosomes.

Authors:  M Brittany Johnson; Louise M Ball; Kylene P Daily; Jennifer N Martin; Linda Columbus; Alison K Criss
Journal:  Cell Microbiol       Date:  2014-11-25       Impact factor: 3.715

8.  Neisseria gonorrhoeae Modulates Cell Death in Human Endocervical Epithelial Cells through Export of Exosome-Associated cIAP2.

Authors:  Kathleen Nudel; Paola Massari; Caroline A Genco
Journal:  Infect Immun       Date:  2015-06-15       Impact factor: 3.441

9.  Chlamydial infection increases gonococcal colonization in a novel murine coinfection model.

Authors:  Rachel A Vonck; T Darville; C M O'Connell; Ann E Jerse
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

10.  Construction and characterization of a derivative of Neisseria gonorrhoeae strain MS11 devoid of all opa genes.

Authors:  Adriana LeVan; Lindsey I Zimmerman; Amanda C Mahle; Karen V Swanson; Philip DeShong; Juhee Park; Vonetta L Edwards; Wenxia Song; Daniel C Stein
Journal:  J Bacteriol       Date:  2012-09-21       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.